Literature DB >> 19644329

Instrumentation and fusion for congenital spine deformities.

Daniel J Hedequist1.   

Abstract

STUDY
DESIGN: A retrospective clinical review.
OBJECTIVE: To review the use of modern instrumentation of the spine for congenital spinal deformities. SUMMARY OF BACKGROUND DATA: Spinal instrumentation has evolved since the advent of the Harrington rod. There is a paucity of literature, which discusses the use of modern spinal instrumentation in congenital spine deformity cases. This review focuses on modern instrumentation techniques for congenital scoliosis and kyphosis.
METHODS: A systematic review was performed of the literature to discuss spinal implant use for congenital deformities.
RESULTS: Spinal instrumentation may be safely and effectively used in cases of congenital spinal deformity.
CONCLUSION: Spinal surgeons taking care of children with congenital spine deformities need to be trained in all aspects of modern spinal instrumentation.

Entities:  

Mesh:

Year:  2009        PMID: 19644329     DOI: 10.1097/BRS.0b013e3181ab62b3

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  3 in total

Review 1.  Early definitive spinal fusion in young children: what we have learned.

Authors:  Lori A Karol
Journal:  Clin Orthop Relat Res       Date:  2011-05       Impact factor: 4.176

2.  The Efficacy of Single-Stage Correction by Posterior Approach for Neglected Congenital Scoliosis: Comparative Analysis According to the Age of Surgical Intervention.

Authors:  Jae Hyuk Yang; Hong Jin Kim; Dong-Gune Chang; Seung Woo Suh; Yunjin Nam; Jae-Young Hong
Journal:  J Clin Med       Date:  2022-04-19       Impact factor: 4.964

3.  Non-fusion and growing instrumentation in the correction of congenital spinal deformity associated with split spinal cord malformation: an early follow-up outcome.

Authors:  Hua Hui; Zhuo-Jing Luo; Ming Yan; Zheng-Xu Ye; Hui-Ren Tao; Hai-Qiang Wang
Journal:  Eur Spine J       Date:  2013-04-05       Impact factor: 3.134

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.